F. Abdul Karim

474 total citations
10 papers, 369 citations indexed

About

F. Abdul Karim is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, F. Abdul Karim has authored 10 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in F. Abdul Karim's work include Hemophilia Treatment and Research (8 papers), Platelet Disorders and Treatments (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). F. Abdul Karim is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Platelet Disorders and Treatments (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). F. Abdul Karim collaborates with scholars based in Denmark, Italy and United Kingdom. F. Abdul Karim's co-authors include Robert Klamroth, B. Brand, C. R. M. Hay, Ute Friedrich, Johnny Mahlangu, Stefan Lethagen, Wolfgang Miesbach, Pantep Angchaisuksiri, Paul Knoebl and Pratima Chowdary and has published in prestigious journals such as Blood, Journal of Thrombosis and Haemostasis and Acta Paediatrica.

In The Last Decade

F. Abdul Karim

10 papers receiving 363 citations

Peers

F. Abdul Karim
Scharrer Germany
Alice S. van Velzen Netherlands
Amy Shapiro United States
Glaivy Batsuli United States
G. Auerswald Germany
M. Oh United States
Avrita Campinha‐Bacote United States
Susan Pemberton United Kingdom
Elizabeth Chalmers United Kingdom
Vilhelmína Haraldsdóttir Iceland
Scharrer Germany
F. Abdul Karim
Citations per year, relative to F. Abdul Karim F. Abdul Karim (= 1×) peers Scharrer

Countries citing papers authored by F. Abdul Karim

Since Specialization
Citations

This map shows the geographic impact of F. Abdul Karim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Abdul Karim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Abdul Karim more than expected).

Fields of papers citing papers by F. Abdul Karim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Abdul Karim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Abdul Karim. The network helps show where F. Abdul Karim may publish in the future.

Co-authorship network of co-authors of F. Abdul Karim

This figure shows the co-authorship network connecting the top 25 collaborators of F. Abdul Karim. A scholar is included among the top collaborators of F. Abdul Karim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Abdul Karim. F. Abdul Karim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Stasyshyn, Oleksandra, Claudia Djambas Khayat, Genadi Iosava, et al.. (2017). Safety, efficacy and pharmacokinetics of rVIII‐SingleChain in children with severe hemophilia A: results of a multicenter clinical trial. Journal of Thrombosis and Haemostasis. 15(4). 636–644. 30 indexed citations
2.
Carção, Manuel, F. Abdul Karim, Hideji Hanabusa, et al.. (2016). Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial. Journal of Thrombosis and Haemostasis. 14(8). 1521–1529. 33 indexed citations
3.
Kavaklı, Kaan, Lynne M. Smith, Kazimierz Kuliczkowski, et al.. (2016). Once‐weekly prophylactic treatment vs. on‐demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B. Haemophilia. 22(3). 381–388. 41 indexed citations
4.
Chowdary, Pratima, Stefan Lethagen, Ute Friedrich, et al.. (2015). Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis. 13(5). 743–754. 179 indexed citations
5.
Jiménez‐Yuste, Víctor, Sandra Lejniece, Robert Klamroth, et al.. (2014). The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A. Journal of Thrombosis and Haemostasis. 13(3). 370–379. 23 indexed citations
6.
7.
Carção, Manuel, Marek Žák, F. Abdul Karim, et al.. (2014). Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients. Blood. 124(21). 1513–1513. 3 indexed citations
8.
9.
Karim, F. Abdul, et al.. (2002). Dieulafoy’s Lesion of the Rectum. Acta chirurgica Belgica. 102(3). 199–200. 2 indexed citations
10.
Emberton, Mark, et al.. (1996). Early repair of inguinal hernia in preterm infants with oxygen‐dependent bronchopulmonary dysplasia. Acta Paediatrica. 85(1). 96–99. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scharrer Breakdown of academic impact, for papers by Alice S. van Velzen Breakdown of academic impact, for papers by Amy Shapiro Breakdown of academic impact, for papers by Glaivy Batsuli Breakdown of academic impact, for papers by G. Auerswald Breakdown of academic impact, for papers by M. Oh Breakdown of academic impact, for papers by Avrita Campinha‐Bacote Breakdown of academic impact, for papers by Susan Pemberton Breakdown of academic impact, for papers by Elizabeth Chalmers Breakdown of academic impact, for papers by Vilhelmína Haraldsdóttir
Rankless by CCL
2026